Results 211 to 220 of about 5,149,759 (252)

Mechanisms by which carbamoylated high-density lipoprotein (C-HDL) promotes calcific aortic valve disease and exploration of potential targeted therapies. [PDF]

Open Life Sci
Han M, Jiang W, Yang Y, Chen R.
europepmc   +1 more source

Preoperative transcutaneous vagus nerve stimulation as a novel strategy to prevent postoperative atrial fibrillation in calcific aortic valve disease: mechanistic insights and translational perspectives. [PDF]

Front Cardiovasc Med
Bergeon J, Chassagne F, Fanget M, Merlet AN, Avril S, Féasson L, Roche F, Bäck M, Hupin D.   +8 more
europepmc   +1 more source

A Study on the Correlation Between Calcific Aortic Valve Disease and Carotid Artery Elasticity. [PDF]

Rev Cardiovasc Med
Zhang Y, Wang H, Zhong Y, Wang W, Zhang Z, He Q.   +5 more
europepmc   +1 more source

Navigating the Landscape of Translational Medicine of Calcific Aortic Valve Disease: Bridging Bench to Bedside. [PDF]

JACC Asia
Qian X, Xu L, Geng B, Li F, Dong N.
europepmc   +1 more source

Global, regional, and national burden of non-rheumatic calcific aortic valve disease from 1990 to 2021, with projections of incidence to 2050: a systematic analysis of the global burden of disease study 2021 and Mendelian randomization analysis. [PDF]

J Cardiothorac Surg
Xia M, Qian C, Luo Y, Wang Y, Peng Y, Zhang C.   +5 more
europepmc   +1 more source

Global, regional, and national burden of nonrheumatic calcific aortic valve disease based on GBD study 2021. [PDF]

Sci Rep
Wang B, Mei Z, Yang H, Gao W, Ma L, An G.   +5 more
europepmc   +1 more source

Association between coronary artery calcium and the progression of calcific aortic valve disease: a hospital population-based observational retrospective cohort study. [PDF]

BMJ Open
Kim HT, Seo JH, Bae JH, Kim TJ, Kim YM, Jo H, Lee SH, Chung HJ, Han DS.   +8 more
europepmc   +1 more source

Diabetes and calcific aortic valve disease: implications of glucose-lowering medication as potential therapy. [PDF]

Front Pharmacol
Liu F, Cai H.
europepmc   +1 more source

Cross-Disease Identification of FBP1 in Atherosclerosis and Calcific Aortic Valve Disease via Integrated Bioinformatics and Validation: Functional Analysis and Therapeutic Target Exploration. [PDF]

J Inflamm Res
Xu H, Xu Y, Wang X, Yan Z, Geng T, Wu J, Li Y, Guo M.   +7 more
europepmc   +1 more source

Atherosclerosis, calcific aortic valve disease and mitral annular calcification: same or different? [PDF]

Int J Cardiol
Hafiane A, Pisaturo A, Favari E, Bortnick AE.   +3 more
europepmc   +1 more source